Park Ha Biological Technology (BYAH) Corporate Presentation summary

Equity and financial overview

• Listed on Nasdaq under ticker PHH with a share price of $8.30 and a market cap of $218.91 million as of March 2025.

• FY2024 revenue was $2.38 million, down from $2.46 million in FY2023, mainly due to lower franchise fees.

• Gross profit margin remained high at 87% in FY2024, with net income at $0.48 million.

• Product sales to non-franchisees accounted for 70% of FY2024 revenue, with franchise fees declining.

Business model and operations

• Operates 3 directly managed stores and 45 franchisee stores across 14 provinces and 1 municipality in China.

• Offers 128 skincare products across 14 series, collaborating with biological labs and third-party manufacturers.

• Provides value-added services like complimentary after-sales beauty sessions in both direct and franchise stores.

• Employs an omnichannel strategy combining e-commerce, social media, and offline experiences.

Corporate structure and milestones

• Parent company based in Cayman Islands with subsidiaries in Hong Kong and mainland China.

• Key milestones include incorporation of major subsidiaries between 2016 and 2025, with the first store launched in 2017.